NasdaqGS - Nasdaq Real Time Price USD

National Research Corporation (NRC)

14.78

+0.41

+(2.89%)

As of 12:39:37 PM EDT. Market Open.

A Look At The Intrinsic Value Of National Research Corporation (NASDAQ:NRC)

Key Insights Using the 2 Stage Free Cash Flow to Equity, National Research fair value estimate is US$14.76 With...

Simply Wall St. 22 days ago

NRC
+2.89%
NRC Health Announces First Quarter Results

LINCOLN, Neb., April 28, 2025--National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the first quarter 2025 and other corporate developments.

Business Wire last month

NRC
+2.89%
Should You Be Impressed By National Research Corporation's (NASDAQ:NRC) ROE?

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

Simply Wall St. last month

NRC
+2.89%
A New Era of Trust: NRC Health’s 2025 Experience Perspective Report Reveals Insights to Elevate the Healthcare Experience

LINCOLN, Neb., April 10, 2025--NRC Health, a recognized leader in healthcare experience management solutions released its 2025 Experience Perspective

Business Wire last month

NRC
+2.89%
National Research (NASDAQ:NRC) Will Pay A Dividend Of $0.12

The board of National Research Corporation ( NASDAQ:NRC ) has announced that it will pay a dividend on the 11th of...

Simply Wall St. 2 months ago

NRC
+2.89%
National Research Corporation Declares Quarterly Dividend

LINCOLN, Neb., March 24, 2025--National Research Corporation, dba NRC Health, (NASDAQ: NRC) announced that its Board of Directors has declared a quarterly cash dividend of $0.12 (twelve cents) per share payable Friday, April 11, 2025, to shareholders of record as of the close of business on Friday, March 28, 2025.

Business Wire 2 months ago

NRC
+2.89%
National Research Full Year 2024 Earnings: EPS: US$1.05 (vs US$1.26 in FY 2023)

National Research ( NASDAQ:NRC ) Full Year 2024 Results Key Financial Results Revenue: US$143.1m (down 3.7% from FY...

Simply Wall St. 2 months ago

NRC
+2.89%
National Research Corporation Appoints Trent Green as Chief Executive Officer

LINCOLN, Neb., March 04, 2025--National Research Corporation (NASDAQ: NRC), doing business as NRC Health, a publicly-traded leader in healthcare improvement, is pleased to announce the appointment of Trent Green as its incoming Chief Executive Officer, effective June 1, 2025. Green will succeed Mike Hays, the company’s current CEO, who will transition to the role of Chairman, ensuring a smooth leadership transition while maintaining NRC Health’s mission-driven and shareholder-focused approach.

Business Wire 3 months ago

NRC
+2.89%
UofL Health Chooses NRC Health to Elevate Patient and Employee Experience Initiatives

LOUISVILLE, Ky., February 25, 2025--UofL Health selects NRC Health to elevate patient and employee experience across its health system.

Business Wire 3 months ago

NRC
+2.89%
Investors five-year losses continue as National Research (NASDAQ:NRC) dips a further 12% this week, earnings continue to decline

Statistically speaking, long term investing is a profitable endeavour. But along the way some stocks are going to...

Simply Wall St. 3 months ago

NRC
+2.89%
NRC Health Partners with UC Health to Enhance Healthcare Consumer Experience

LINCOLN, Neb., February 11, 2025--NRC Health is proud to partner with UC Health, a relationship designed to support the evolving needs of the patients, consumers, and broader communities UC Health serves.

Business Wire 3 months ago

NRC
+2.89%
NRC Health ranked #1 Best in KLAS for Healthcare Experience Management

LINCOLN, Neb., February 05, 2025--NRC Health, a leader in advanced technology and data-driven insights to deliver Human Understanding across the healthcare ecosystem, has proudly announced its recognition as the recipient of the esteemed 2025 Best in KLAS Award for Healthcare Experience Management for the second time in three years.

Business Wire 3 months ago

NRC
+2.89%
National Research Corporation Announces Fourth Quarter Results

LINCOLN, Neb., January 27, 2025--National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the fourth quarter 2024 and other corporate developments.

Business Wire 4 months ago

NRC
+2.89%
National Research Corporation (NASDAQ:NRC) is a favorite amongst institutional investors who own 53%

Key Insights Given the large stake in the stock by institutions, National Research's stock price might be vulnerable to...

Simply Wall St. 4 months ago

NRC
+2.89%
Renown Health selects NRC Health as partner to enhance patient experience and operational efficiency

RENO, Nev., January 07, 2025--Renown Health has selected NRC Health to enhance its network through human-centered healthcare solutions and next-generation, data-driven insights.

Business Wire 4 months ago

NRC
+2.89%
National Research (NASDAQ:NRC) Has Affirmed Its Dividend Of $0.12

The board of National Research Corporation ( NASDAQ:NRC ) has announced that it will pay a dividend of $0.12 per share...

Simply Wall St. 5 months ago

NRC
+2.89%
National Research (NASDAQ:NRC) Will Want To Turn Around Its Return Trends

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Typically, we'll...

Simply Wall St. 6 months ago

NRC
+2.89%
Signature Healthcare Elevates Patient Experience and Workforce Engagement Through Strategic Partnership With NRC Health

LINCOLN, Neb., November 20, 2024--Signature Healthcare has selected NRC Health to enhance its network through human-centered healthcare solutions and data-driven insights.

Business Wire 6 months ago

NRC
+2.89%
Cooper University Health Care Selects NRC Health as New Patient Experience Partner

LINCOLN, Neb., November 12, 2024--Cooper University Health Care has selected NRC Health to be its partner in building Human Understanding across its network through humanized healthcare solutions and data-driven insights inline with Cooper’s mission: "To serve, to heal, to educate."

Business Wire 6 months ago

NRC
+2.89%
National Research (NASDAQ:NRC) Has Announced A Dividend Of $0.12

National Research Corporation's ( NASDAQ:NRC ) investors are due to receive a payment of $0.12 per share on 10th of...

Simply Wall St. 7 months ago

NRC
+2.89%

Performance Overview

Return	NRC	S&P 500 (^GSPC)
YTD	-15.46%	+1.90%
1-Year	-43.45%	+11.97%
3-Year	-56.74%	+45.42%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

National Research Corporation (NRC)

A Look At The Intrinsic Value Of National Research Corporation (NASDAQ:NRC)

NRC Health Announces First Quarter Results

Should You Be Impressed By National Research Corporation's (NASDAQ:NRC) ROE?

A New Era of Trust: NRC Health’s 2025 Experience Perspective Report Reveals Insights to Elevate the Healthcare Experience

National Research (NASDAQ:NRC) Will Pay A Dividend Of $0.12

National Research Corporation Declares Quarterly Dividend

National Research Full Year 2024 Earnings: EPS: US$1.05 (vs US$1.26 in FY 2023)

National Research Corporation Appoints Trent Green as Chief Executive Officer

UofL Health Chooses NRC Health to Elevate Patient and Employee Experience Initiatives

Investors five-year losses continue as National Research (NASDAQ:NRC) dips a further 12% this week, earnings continue to decline

NRC Health Partners with UC Health to Enhance Healthcare Consumer Experience

NRC Health ranked #1 Best in KLAS for Healthcare Experience Management

National Research Corporation Announces Fourth Quarter Results

National Research Corporation (NASDAQ:NRC) is a favorite amongst institutional investors who own 53%

Renown Health selects NRC Health as partner to enhance patient experience and operational efficiency

National Research (NASDAQ:NRC) Has Affirmed Its Dividend Of $0.12

National Research (NASDAQ:NRC) Will Want To Turn Around Its Return Trends

Signature Healthcare Elevates Patient Experience and Workforce Engagement Through Strategic Partnership With NRC Health

Cooper University Health Care Selects NRC Health as New Patient Experience Partner

National Research (NASDAQ:NRC) Has Announced A Dividend Of $0.12

Performance Overview